XML 20 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Operating activities:    
Net loss $ (2,174,430) $ (10,507,869)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,889,272 952,320
Purchase accounting valuation allowance (17,537,408) 0
Non-cash interest 4,107,225 814,374
Impairment of Assets 956,395 912,549
(Gain)/Loss on sale of fixed assets (596,883) 25,269
Amortization of debt discount 707,281 1,632,245
Non-cash consulting expense/stock option expense 836,741 935,316
Provision for losses on accounts receivable and inventory 700,234 647,765
Change in derivative warrant liability (270,020) (1,736,053)
Non-cash consideration associated with stock purchase agreement 558,185 0
Extinguishment of debt (2,345,019) 0
Changes in operating assets and liabilities:    
Accounts receivable (5,512,429) 283,624
Inventories (545,713) (17,392)
Prepaid and other assets (1,044,962) (455,048)
Accounts payable 644,149 715,706
Accrued liabilities 7,527,514 (1,526,865)
Net cash used in operating activities (9,099,868) (7,324,059)
Investing activities:    
Acquisition of X-spine Systems, Inc. (72,975,200) 0
Purchases of property and equipment and intangible assets (2,263,033) (299,978)
Proceeds from sale of fixed assets 1,667,195 1,626
Net cash used in investing activities (73,571,038) (298,352)
Financing activities:    
Proceeds from long-term and convertible debt, net of deferred and financing costs 83,897,361 4,000,000
Net proceeds from equity private placement 515,395 0
Payment of royalty obligation (542,905)  
Payments on long-term debt (1,325,814) (653,397)
Payments on capital leases (101,760) (171,957)
Proceeds from exercise of options 11,500 0
Net proceeds from issuance of stock 2,116,937 5,869,633
Net cash provided by financing activities 84,570,714 9,044,279
Net change in cash and cash equivalents 1,899,808 1,421,868
Cash and cash equivalents at beginning of period 4,468,208 3,046,340
Cash and cash equivalents at end of period $ 6,368,016 $ 4,468,208